The US FDA has just added
Q&A #27 (page 35) to its guidance document today, Wednesday, 27Jan2021 regarding subjects receiving COVID-19 vaccine and/or treatment authorized under an Emergency Use Authorization (EUA).
------------------------------
Aldwin Aldana
Director, Clinical QA and GxP Compliance
Cambridge MA
United States
------------------------------